Cndap Partners With Takeda To Develop New Therapies For Alzheimer's Disease And Related Brain Disorders

by prnewswire.com posted 1month ago 18 views
SAN FRANSISCO, June 16, 2021 /PRNewswire/ -- Cure Network Dolby Acceleration Partners LLC (CNDAP) and Takeda Pharmaceutical Company Limited ("Takeda") have entered into a research collaboration to develop small molecules targeting tau, a protein involved in Alzheimer's disease and other...

In this article

No tags related to this article.